Neuroscience News and Research

RSS

SUMO protein regulates transfer of information between nerve cells in the brain

A key protein, which may be activated to protect nerve cells from damage during heart failure or epileptic seizure, has been found to regulate the transfer of information between nerve cells in the brain. The discovery, made by neuroscientists at the University of Bristol and published in Nature Neuroscience and PNAS, could lead to novel new therapies for stroke and epilepsy.

23 Apr 2012

MTR can prevent cell death after traumatic brain injury

Wake Forest Baptist Medical Center researchers seeking a successful treatment for traumatic brain injury have found that the size and extent of damaged tissue can be reduced by using a new device to prevent cell death.

21 Apr 2012

LCIG improves quality of life, reduces symptoms of Parkinson's

A recent clinical trial conducted at Evergreen Healthcare shows that a new form of a common drug used to treat Parkinson's Disease greatly improves the quality of life for patients and reduces the affects of symptoms such as tremors, slowness, stiffness and difficulty walking.

21 Apr 2012

NSF announces 2012 Graduate Research Fellows

From cognitive neuroscience to theoretical physics, this year's National Science Foundation (NSF) Graduate Research Fellows from the University of Houston (UH) have their sights set on careers in fields ranging from medicine to energy.

21 Apr 2012

First treatment guidelines for NMDA-receptor encephalitis

A mysterious, difficult-to-diagnose, and potentially deadly disease that was only recently discovered can be controlled most effectively if treatment is started within the first month that symptoms occur, according to a new report by researchers from the Perelman School of Medicine at the University of Pennsylvania.

21 Apr 2012

TPU, Eisai amend Aricept patch licensing agreement

Eisai announced today that the company has amended the licensing agreement with Teikoku Pharma USA, Inc. (TPU), a subsidiary of Teikoku Seiyaku Co., Ltd., pertaining to exclusive overseas marketing rights for the Aricept patch (once weekly donepezil HCl transdermal system).

21 Apr 2012

First study to quantify effects of AD plaques on brain networks in animal model

Scientists studying the way Alzheimer's takes root in the brain have identified important new similarities between a mouse model and human Alzheimer's.

21 Apr 2012

K. Hovnanian Children's Hospital announces opening of new specialty care center

K. Hovnanian Children's Hospital at Jersey Shore University Medical Center is proud to announce the grand opening of K. Hovnanian Children's Hospital Specialty Care Center, a consolidated outpatient pediatric center serving as the new home of Meridian Pediatric Associates. The center provides pediatric specialty care services in a comfortable and friendly environment, and is an important first step of the hospital's new pediatric expansion project.

20 Apr 2012

Kessler Foundation scientist to develop predictive model of unemployment in MS

Lauren Strober, PhD, has been awarded a five-year federal grant for $554,000 to study factors relating to unemployment in people with multiple sclerosis (MS). Dr. Strober is a research scientist at Kessler Foundation, a major center for cognitive research and training in multiple sclerosis and a leader in the field of disability employment.

20 Apr 2012

Longer looks: Rushed medicine; Exercising your way to a smarter brain

Something in the world of medicine is seriously amiss. Unhappy patients gripe about their doctors' brusque manner and give them bad marks on surveys and consumer websites like HealthGrades and Angie's List. They tell tales of being rushed out of the office by harried doctors who miss crucial diagnoses, never look up from their computers during an exam, make errors in prescriptions, and just plain don't listen to their patients. ... And things don't seem much better from the other side of the stethoscope.

20 Apr 2012

JSUMC launches Soiree at the Shore event

This year the Jersey Shore University Medical Center Foundation is proud to announce the launch of Soiree at the Shore, a new and exciting event taking the calendar date of the successful Runway on the River.

20 Apr 2012

New technology delivers electrical signals from brain directly to muscles

A new Northwestern Medicine brain-machine technology delivers messages from the brain directly to the muscles -- bypassing the spinal cord -- to enable voluntary and complex movement of a paralyzed hand. The device could eventually be tested on, and perhaps aid, paralyzed patients.

20 Apr 2012

Breakdown of white-matter pathways affects decision-making as we age

If you are an aging baby boomer and you've noticed it's a bit harder to drive to unfamiliar locations or to pick a new brand of olive oil at the supermarket, you can blame it on the white matter in your brain.

20 Apr 2012

Interferon beta-1a shows promise against MS

People who received injections of the multiple sclerosis (MS) drug interferon beta-1a soon after their first signs of possible MS were less likely to progress to clinically definite MS than people who switched to interferon beta-1a from placebo, according to new phase three results of the three-year REFLEXION clinical trial that will be presented as part of the Emerging Science program at the American Academy of Neurology's 64th Annual Meeting in New Orleans, April 21 to April 28, 2012.

20 Apr 2012

Social status can affect configuration of neural circuitry

Researchers at Georgia State University have discovered that in one species of freshwater crustaceans, social status can affect the configuration of neural circuitry.

20 Apr 2012

Researchers discover new stem cell in the adult brain

Researchers at Lund University in Sweden have discovered a new stem cell in the adult brain. These cells can proliferate and form several different cell types -- most importantly, they can form new brain cells. Scientists hope to take advantage of the finding to develop methods to heal and repair disease and injury in the brain.

20 Apr 2012

Palatin, AstraZeneca initiate second AZD2820 phase I trial in obesity

Palatin Technologies, Inc. today announced that a second phase I clinical trial of AZD2820, a subcutaneously-administered peptide melanocortin receptor partial agonist under development for the treatment of obesity, has commenced.

20 Apr 2012

Even a little physical activity a day keeps Alzheimer’s away

It is estimated that by 2030, the number of people with Alzheimer's disease worldwide is expected to double to 80 million. A new study shows a ray of hope. It found that daily physical activity might provide a person's best chances of staving off the degenerative brain disorder - even if they're over 80 years old.Additionally exercise does not have to be strenuous. Activities such as cooking and cleaning also led to a protective benefit.

19 Apr 2012

Physical exercise, meditation can change brains for the better

Practices like physical exercise, certain forms of psychological counseling and meditation can all change brains for the better, and these changes can be measured with the tools of modern neuroscience, according to a review article now online at Nature Neuroscience.

19 Apr 2012

UCSF scientists solve mystery of how selective hearing works

The longstanding mystery of how selective hearing works - how people can tune in to a single speaker while tuning out their crowded, noisy environs - is solved this week in the journal Nature by two scientists from the University of California, San Francisco.

19 Apr 2012